Literature DB >> 22194601

Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.

Gaylor Boulay1, Nicolas Malaquin, Ingrid Loison, Bénédicte Foveau, Capucine Van Rechem, Brian R Rood, Albin Pourtier, Dominique Leprince.   

Abstract

The transcriptional repressor HIC1 (Hypermethylated in Cancer 1) is a tumor suppressor gene inactivated in many human cancers including breast carcinomas. In this study, we show that HIC1 is a direct transcriptional repressor of β-2 adrenergic receptor (ADRB2). Through promoter luciferase activity, chromatin immunoprecipitation (ChIP) and sequential ChIP experiments, we demonstrate that ADRB2 is a direct target gene of HIC1, endogenously in WI-38 cells and following HIC1 re-expression in breast cancer cells. Agonist-mediated stimulation of ADRB2 increases the migration and invasion of highly malignant MDA-MB-231 breast cancer cells but these effects are abolished following HIC1 re-expression or specific down-regulation of ADRB2 by siRNA treatment. Our results suggest that early inactivation of HIC1 in breast carcinomas could predispose to stress-induced metastasis through up-regulation of the β-2 adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22194601      PMCID: PMC3285317          DOI: 10.1074/jbc.M111.304287

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.

Authors:  A E Vilgelm; S-M Hong; M K Washington; J Wei; H Chen; W El-Rifai; A Zaika
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

2.  The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).

Authors:  Bénédicte Foveau; Gaylor Boulay; Sébastien Pinte; Capucine Van Rechem; Brian R Rood; Dominique Leprince
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

3.  Signaling pathways of isoproterenol-induced ERK1/2 phosphorylation in primary cultures of astrocytes are concentration-dependent.

Authors:  Ting Du; Baoman Li; Hongmei Li; Min Li; Leif Hertz; Liang Peng
Journal:  J Neurochem       Date:  2010-10-05       Impact factor: 5.372

4.  Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells.

Authors:  T A Slotkin; J Zhang; R Dancel; S J Garcia; C Willis; F J Seidler
Journal:  Breast Cancer Res Treat       Date:  2000-03       Impact factor: 4.872

5.  Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.

Authors:  Mian M K Shahzad; Jesusa M Arevalo; Guillermo N Armaiz-Pena; Chunhua Lu; Rebecca L Stone; Myrthala Moreno-Smith; Masato Nishimura; Jeong-Won Lee; Nicholas B Jennings; Justin Bottsford-Miller; Pablo Vivas-Mejia; Susan K Lutgendorf; Gabriel Lopez-Berestein; Menashe Bar-Eli; Steven W Cole; Anil K Sood
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

6.  The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.

Authors:  Sophie Deltour; Sébastien Pinte; Cateline Guerardel; Bohdan Wasylyk; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

7.  Loss of a single Hic1 allele accelerates polyp formation in Apc(Δ716) mice.

Authors:  H P Mohammad; W Zhang; H S Prevas; B R Leadem; M Zhang; J G Herman; C M Hooker; D N Watkins; B Karim; D L Huso; S B Baylin
Journal:  Oncogene       Date:  2011-02-07       Impact factor: 9.867

8.  Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.

Authors:  Desmond G Powe; Melanie J Voss; Kurt S Zänker; Hany O Habashy; Andrew R Green; Ian O Ellis; Frank Entschladen
Journal:  Oncotarget       Date:  2010-11

9.  Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.

Authors:  G Nicoll; D N Crichton; H E McDowell; N Kernohan; T R Hupp; A M Thompson
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

10.  Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.

Authors:  Savithri Rangarajan; Jorrit M Enserink; H Bea Kuiperij; Johan de Rooij; Leo S Price; Frank Schwede; Johannes L Bos
Journal:  J Cell Biol       Date:  2003-02-10       Impact factor: 10.539

View more
  18 in total

1.  Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.

Authors:  Gaylor Boulay; Marion Dubuissez; Capucine Van Rechem; Antoine Forget; Kristian Helin; Olivier Ayrault; Dominique Leprince
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

2.  The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).

Authors:  Bénédicte Foveau; Gaylor Boulay; Sébastien Pinte; Capucine Van Rechem; Brian R Rood; Dominique Leprince
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

3.  DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.

Authors:  Vanessa Dehennaut; Ingrid Loison; Marion Dubuissez; Joe Nassour; Corinne Abbadie; Dominique Leprince
Journal:  J Biol Chem       Date:  2013-02-15       Impact factor: 5.157

4.  Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.

Authors:  Jianghua Zheng; Dan Xiong; Xueqing Sun; Jinglong Wang; Mingang Hao; Tao Ding; Gang Xiao; Xiumin Wang; Yan Mao; Yuejie Fu; Kunwei Shen; Jianhua Wang
Journal:  Cancer Microenviron       Date:  2012-04-13

5.  BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.

Authors:  Yan-jun Zhang; Lichun Wei; Mei Liu; Jie Li; Yi-qiong Zheng; Ying Gao; Xi-ru Li
Journal:  Tumour Biol       Date:  2013-02-19

6.  HIC1 interacts with and modulates the activity of STAT3.

Authors:  Ying-Mei Lin; Chia-Mei Wang; Jen-Chong Jeng; Dominique Leprince; Hsiu-Ming Shih
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

Review 7.  Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.

Authors:  Brian R Rood; Dominique Leprince
Journal:  Expert Opin Ther Targets       Date:  2013-04-09       Impact factor: 6.902

8.  HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk.

Authors:  Yingying Wang; Xiaoling Weng; Luoyang Wang; Mingang Hao; Yue Li; Lidan Hou; Yu Liang; Tianqi Wu; Mengfei Yao; Guowen Lin; Yiwei Jiang; Guohui Fu; Zhaoyuan Hou; Xiangjun Meng; Jinsong Lu; Jianhua Wang
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

9.  CCL2 Induces the Production of β2 Adrenergic Receptors and Modifies Astrocytic Responses to Noradrenaline.

Authors:  Irene L Gutiérrez; Marta González-Prieto; Borja García-Bueno; Javier R Caso; Douglas L Feinstein; José L M Madrigal
Journal:  Mol Neurobiol       Date:  2018-02-24       Impact factor: 5.590

10.  Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancer.

Authors:  Feng Zhao; Shengli Pan; Yan Gu; Shanyu Guo; Qiancheng Dai; Yingyan Yu; Wei Zhang
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.